Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Dutch Cancer Society
Dutch Cancer Society (Netherlands)
Update Il y a 4 ans
Neoadjuvant chemoradiation followed by surgery versus surgery alone for patients with adenocarcinomas or squamous cell carcinomas of the esophagus
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Man Max 99 years
Dutch Cancer Society
Update Il y a 4 ans
Patient involvement in prostate cancer treatment decisions
Not provided at time of registration
Country
Netherlands
organs
None
Specialty
None
Closed trial
More information
Woman Max 99 years
Dutch Cancer Society (Netherlands)
Update Il y a 4 ans
The Sex Hormones And Physical Exercise study
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Dutch Cancer Society and Maastricht University (The Netherlands)
Update Il y a 4 ans
OncoRev study: effect of a multi-disciplinary rehabilitation program for cancer patients on quality of life - a randomised controlled multicentre trial
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Dutch Cancer Society
Update Il y a 4 ans
Reduced intensity chemotherapy given with and without imatinib mesylate in patients >/= 60 years considered unfit for standard chemotherapy with previously untreated acute myeloid leukemia (AML) and refractory anemia with excess of blasts (RAEB), refractory anemia with excess blasts in transformation (RAEB-T): a randomized phase II study
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Dutch Cancer Society
Update Il y a 4 ans
Neo-adjuvant Simvastatin therapy in colorectal cancer
To ascertain whether orally delivered Simvastatin affects levels of apoptosis, proliferation and bone morphogenetic protein pathway activation in colorectal cancer in humans.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Dutch Cancer Society and Schering AG (Netherlands)
Update Il y a 4 ans
A randomized phase III study in previously untreated patients with biological high-risk CLL: fludarabine and cyclophosphamide (FC) versus FC and low-dose alemtuzumab
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information